Related Experiment Videos
Membrane damage by bile salts: the protective function of phospholipids
The Journal of Pharmacy and Pharmacology
|December 1, 1981
Summary
Phosphatidylcholine (PC) protects biological membranes from surfactants like sodium deoxycholate (SDC) and lysophosphatidylcholine (LPC). This finding is significant for understanding gastric ulceration and developing safer drug delivery systems.
Area of Science:
- Biochemistry
- Toxicology
- Membrane Biology
Background:
- Sodium deoxycholate (SDC) and lysophosphatidylcholine (LPC) are known to directly damage biological membranes.
- Understanding the protective mechanisms against such damage is crucial for both physiological and pharmacological applications.
Purpose of the Study:
- To assess the direct toxicity of SDC and LPC on biological membranes.
- To investigate the protective role of phosphatidylcholine (PC) against SDC and LPC toxicity.
- To explore the implications of these findings for gastric ulceration and drug delivery systems.
Main Methods:
- Goldfish overturn time was used to measure the direct toxicity of SDC and LPC.
- Fish were pretreated with SDC alone or SDC with PC before exposure to quinalbarbitone sodium.
- The protective effect of PC against sodium dodecyl sulphate-induced membrane damage was also evaluated.
Main Results:
- Incorporating PC into the media reduced the toxicity of SDC and LPC, indicated by increased overturn times.
- Pretreatment with SDC alone showed dose-dependent toxicity, with direct toxicity observed after 40 minutes.
- Pretreatment with SDC and PC offered significant protection against barbiturate challenge, with protective effects increasing linearly with pretreatment time.
- PC also protected against membrane damage caused by sodium dodecyl sulphate.
Conclusions:
- Phosphatidylcholine (PC) effectively mitigates the membrane-damaging effects of SDC and LPC.
- Mixed micelle formation between PC and surfactants is the likely mechanism for this protective effect.
- These findings have implications for the gastrointestinal reflux hypothesis of ulceration and the design of drug delivery systems to minimize mucosal damage.